Member Info for Hartlebury

And sequencing capacity

Last I heard was 30% of tests being sequenced in Uk with 100% goal...obviously this changes all the time according to the number of positive tests.

Couldn’t it come under extension of Phase1?

I think it’s pretty much what I said and you are arguing for, how to release a ‘new’ rns to pacify shareholders when there is maybe nothing new to say!

That’s good though Obelix...my ears would have pricked up had he seemed less confident or mentioned emerging tech to threaten NCYT’s market leading position? In the absence of new good news it’s also helpful to have confirmation of status quo being intact!

It’s worth a listen, VA clearly still very pro Novacyt. Particularly interesting comments at the end about how he sees hospital testing in future wrt to panel assays ‘if a patient presents with respiratory symptoms then you are going to want to know, do they have flu, rsv, COVID-1/2/3.’...he doesn’t reference Nova but we all know whose tests do exactly that!

Not sure how he can win on that front Shareguy, if he stays silent everyone speculates, if he has nothing material he can disclose then the occasional tweet, however banal, at least gives evidence that he’s still around and hopefully making progress!

With Zak Mir

https://www.share-talk.com/vadim-alexandre-healthcare-analyst-sp-angel-talks-diagnostic-stocks/

Hope all goes well Wilson, see you very soon!

No, Accula is the POC test belonging to MESA that was acquired by TF, discussed in the article.

Another Jekyll and Hyde....you weren’t as pessimistic yesterday Shareguy, what has suddenly changed?

You can never tell around here Parm ;-)

It’s going to take some poor bu**er a long time to call everyone on the shareholder list and offer them a share buyback!

Err no, SYME would not have a list of PI shareholders and their personal details - unless brokers everywhere are breaching data protection laws!

Lol

Interesting article. Wonder if NCYT involved?
https://apple.news/A1XxHtkxbQyWzgL-dlleOAQ

FCA normal deadline for release would be end of April (4m after end of year date) but 2 months extra is currently being allowed due to covid.

And auditors not audit forms (should proofread)

Apologies, mid July would be 6m deadline

Gosia I have wondered if FCA might require publication of next set of audited results before restoration, purely for clarity in the market, which the company has sidestepped (intentionally or not) by moving the accounting reference dates. The deadline for those would normally be end of April but FCA are currently giving an extra 2 months grace due to covid. June would also be 6 month deadline after which FCA could (but not necessarily would) cancel a listing. Really hope we don’t have to wait that long but I know audit forms are insanely busy at the moment so if it is the situation we may have to be patient and trust AZ to get funding sorted and business happening. Would expect to see updates on all fronts.